Tatiana Kisseleva, David A. Brenner  Journal of Hepatology 

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
The impact of hepatitis E in the liver transplant setting
Reactive oxygen species in the normal and acutely injured liver
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Hedgehog signaling in the liver
Stem cell therapies for liver failure and cirrhosis
Immigration and viral hepatitis
Volume 139, Issue 3, Pages (September 2010)
Living donor liver transplantation: is the hype over?
Senescence: Not Just for Tumor Suppression
The origin of cancer stem cells
Mechanisms of Hepatic Fibrogenesis
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
Mesenchymal stromal cell therapy for liver diseases
The immunophenotype of antigen presenting cells of the mononuclear phagocyte system in normal human liver – A systematic review  Otto Strauss, P. Rod.
Hepatitis C core protein – The “core” of immune deception?
Vincent Leroy, Jean-Pierre Zarski  Journal of Hepatology 
Jay A. Graham, James V. Guarrera  Journal of Hepatology 
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Atsushi Miyajima, Minoru Tanaka, Tohru Itoh  Cell Stem Cell 
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: Molecular networks and biological concepts  Chiara Raggi, Pietro Invernizzi,
Ariane Mallat, Sophie Lotersztajn  Journal of Hepatology 
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Figure 2 Developmental and alternative sources of fibroblasts
Approaches for treatment of liver fibrosis in chronic hepatitis C
Volume 59, Issue 3, Pages (September 2013)
EASL Clinical Practice Guidelines: Wilson’s disease
Volume 37, Issue 3, Pages (September 2002)
EASL Recognition Award Recipient 2017: Prof. Giorgina Mieli-Vergani
Veronika Lukacs-Kornek, Detlef Schuppan  Journal of Hepatology 
Volume 66, Issue 1, Pages (January 2017)
Liver stem cells and model systems for liver repopulation
Liver fibrosis – from bench to bedside
Fibrosis in chronic liver diseases: diagnosis and management
Volume 50, Issue 4, Pages (April 2009)
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Liver stem cells—prospects for clinical use
Paul C. Adams, James C. Barton  Journal of Hepatology 
miR-122 – A key factor and therapeutic target in liver disease
Immigration and viral hepatitis
The potential of induced pluripotent stem cell derived hepatocytes
Global burden of alcoholic liver diseases
Mesenchymal Stem Cells in Fibrotic Disease
Role of desmoplasia in cholangiocarcinoma and hepatocellular carcinoma
Volume 63, Issue 1, Pages (July 2015)
Macrophage heterogeneity in liver injury and fibrosis
The dynamic biliary epithelia: Molecules, pathways, and disease
Valerie S. LeBleu, Raghu Kalluri  Kidney International 
Volume 62, Issue 3, Pages (March 2015)
Silvia Affò, Ramón Bataller  Journal of Hepatology 
Volume 132, Issue 5, Pages (May 2007)
HCV animal models and liver disease
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
Corrigendum to “Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury” [J Hepatol 49 (2008) 88–98]  Angela Douglass,
740. Prevention of Radiation-Induced Lung Injury by Administration of Gene-Modified Mesenchymal Stem Cells    Molecular Therapy  Volume 20, Pages S285-S286.
Volume 61, Issue 2, Pages (August 2014)
Platelets arrive at the scene of fibrosis……studies
Presentation transcript:

The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosis  Tatiana Kisseleva, David A. Brenner  Journal of Hepatology  Volume 56, Issue 4, Pages 965-972 (April 2012) DOI: 10.1016/j.jhep.2011.09.021 Copyright © 2012 Terms and Conditions

Fig. 1 Possible origins of fibrogenic myofibroblasts. Hepatic myofibroblasts may originate from liver resident mesenchymal cells. These include hepatic stellate cells, which under physiological conditions reside in the space of Disse in a quiescent state, and in response to injury undergo activation into myofibroblasts. Portal fibroblasts may also be a source of myofibroblasts in the fibrotic liver. In addition, BM-derived hematopoietic and mesenchymal cells may contribute to the myofibroblast population. While the role of mesenchymal stem cells in liver fibrosis is not well characterized due to the lack of specific markers and difficulties with their isolation, hematopoietic stem cells contribute to hepatic fibrocytes in response to liver injury. Journal of Hepatology 2012 56, 965-972DOI: (10.1016/j.jhep.2011.09.021) Copyright © 2012 Terms and Conditions

Fig. 2 Potential roles of BM-derived progenitor populations in liver injury. BM is the source of hematopoietic and mesenchymal stem cells, which may participate in the response to liver injury. Journal of Hepatology 2012 56, 965-972DOI: (10.1016/j.jhep.2011.09.021) Copyright © 2012 Terms and Conditions

Journal of Hepatology 2012 56, 965-972DOI: (10. 1016/j. jhep. 2011. 09 Copyright © 2012 Terms and Conditions

Journal of Hepatology 2012 56, 965-972DOI: (10. 1016/j. jhep. 2011. 09 Copyright © 2012 Terms and Conditions

Journal of Hepatology 2012 56, 965-972DOI: (10. 1016/j. jhep. 2011. 09 Copyright © 2012 Terms and Conditions